Protection conferred by virus-like particle vaccines against respiratory syncytial virus infection in mice by intranasal vaccination

References

• Mejias A, Chavez-Bueno S, Jafri HS, Ramilo O. Respiratory syncytial virus infections: old challenges and new opportunities. Pediatr Infect Dis J 2005; 24:S189-96, discussion S96-7; PMID:16378045; http://dx.doi.org/10.1097/01.inf.0000188196.87969.9a
   PubMedGoogle Scholar
• Stokes KL, Currier MG, Sakamoto K, Lee S, Collins PL, Plemper RK, Moore ML. The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection. J Virol 2013; 87:10070-82; PMID:23843644; http://dx.doi.org/10.1128/JVI.01347-13
   PubMed Web of Science ®Google Scholar
• Hurwitz JL. Respiratory syncytial virus vaccine development. Expert Rev Vaccines 2011; 10:1415-33; PMID:21988307; http://dx.doi.org/10.1586/erv.11.120
   PubMed Web of Science ®Google Scholar
• Wright M, Piedimonte G. Respiratory syncytial virus prevention and therapy: past, present, and future. Pediatr Pulmonol 2011; 46:324-47; PMID:21438168; http://dx.doi.org/10.1002/ppul.21377
   PubMed Web of Science ®Google Scholar
• Roldao A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM. Virus-like particles in vaccine development. Expert Rev Vaccines 2010; 9:1149-76; PMID:20923267; http://dx.doi.org/10.1586/erv.10.115
   PubMed Web of Science ®Google Scholar
• Murawski MR, McGinnes LW, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Heaton PM, Fraire AE, Morrison TG. Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology. J Virol 2010; 84:1110-23; PMID:19889768; http://dx.doi.org/10.1128/JVI.01709-09
   PubMed Web of Science ®Google Scholar
• Quan FS, Kim Y, Lee S, Yi H, Kang SM, Bozja J, Moore ML, Compans RW. Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice. J Infect Dis 2011; 204:987-95; PMID:21881112; http://dx.doi.org/10.1093/infdis/jir474
   PubMed Web of Science ®Google Scholar
• Mena JA, Kamen AA. Insect cell technology is a versatile and robust vaccine manufacturing platform. Expert Rev Vaccines 2011; 10:1063-81; PMID:21806400; http://dx.doi.org/10.1586/erv.11.24
   PubMed Web of Science ®Google Scholar
• Deschuyteneer M, Elouahabi A, Plainchamp D, Plisnier M, Soete D, Corazza Y, Lockman L, Giannini S, Deschamps M. Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine. Hum Vaccines 2010; 6:407-19; PMID:20953154; http://dx.doi.org/10.4161/hv.6.5.11023
   PubMed Web of Science ®Google Scholar
• Munoz FM, Piedra PA, Glezen WP. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine 2003; 21:3465-7; PMID:12850361; http://dx.doi.org/10.1016/S0264-410X(03)00352-9
   PubMed Web of Science ®Google Scholar
• Singh SR, Dennis VA, Carter CL, Pillai SR, Jefferson A, Sahi SV, Moore EG. Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model. Vaccine 2007; 25:6211-23; PMID:17629376; http://dx.doi.org/10.1016/j.vaccine.2007.05.068
   PubMed Web of Science ®Google Scholar
• Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy–a review. Virus Genes 2006; 33:235-52; PMID:16972040
   PubMed Web of Science ®Google Scholar
• Wahl M, Hermodsson S. Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response. Scand J Infect Dis 1987; 19:617-21; PMID:3441747; http://dx.doi.org/10.3109/00365548709117195
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Induction of secretory immunity and memory at mucosal surfaces. Vaccine 2007; 25:5467-84; PMID:17227687; http://dx.doi.org/10.1016/j.vaccine.2006.12.001
   PubMed Web of Science ®Google Scholar
• Corthesy B. Role of secretory IgA in infection and maintenance of homeostasis. Autoimmu Rev 2013; 12:661-5; PMID:23201924; http://dx.doi.org/10.1016/j.autrev.2012.10.012
   PubMed Web of Science ®Google Scholar
• van Riet E, Ainai A, Suzuki T, Hasegawa H. Mucosal IgA responses in influenza virus infections; thoughts for vaccine design. Vaccine 2012; 30:5893-900; PMID:22835738; http://dx.doi.org/10.1016/j.vaccine.2012.04.109
   PubMed Web of Science ®Google Scholar
• Patel H, Yewale C, Rathi MN, Misra A. Mucosal immunization: a review of strategies and challenges. Crit Rev Ther Drug Carrier Syst 2014; 31:273-303; PMID:25072196; http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.2014010102
   PubMed Web of Science ®Google Scholar
• Kupsch J, Saizawa KM, Eichmann K. Expression of murine soluble CD4 protein in baculovirus infected insect cells. Immunobiology 1992; 186:254-67; PMID:1490731; http://dx.doi.org/10.1016/S0171-2985(11)80255-X
   PubMedGoogle Scholar
• Rudan I, O'Brien KL, Nair H, Liu L, Theodoratou E, Qazi S, Luksic I, Fischer Walker CL, Black RE, Campbell H, et al. Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health 2013; 3:010401; PMID:23826505; http://dx.doi.org/10.7189/jogh.03.010101
   PubMed Web of Science ®Google Scholar
• Blanco JC, Boukhvalova MS, Shirey KA, Prince GA, Vogel SN. New insights for development of a safe and protective RSV vaccine. Hum Vaccines 2010; 6:482-92; PMID:20671419; http://dx.doi.org/10.4161/hv.6.6.11562
   PubMed Web of Science ®Google Scholar
• Correia BE, Bates JT, Loomis RJ, Baneyx G, Carrico C, Jardine JG, Rupert P, Correnti C, Kalyuzhniy O, Vittal V, et al. Proof of principle for epitope-focused vaccine design. Nature 2014; 507:201-6; PMID:24499818; http://dx.doi.org/10.1038/nature12966
   PubMed Web of Science ®Google Scholar
• McGinnes LW, Gravel KA, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Schmidt MR, Morrison TG. Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins. J Virol 2011; 85:366-77; PMID:20980510; http://dx.doi.org/10.1128/JVI.01861-10
   PubMed Web of Science ®Google Scholar
• Falsey AR, Singh HK, Walsh EE. Serum antibody decay in adults following natural respiratory syncytial virus infection. J Med Virol 2006; 78:1493-7; PMID:16998887; http://dx.doi.org/10.1002/jmv.20724
   PubMed Web of Science ®Google Scholar
• Domachowske JB, Rosenberg HF. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev 1999; 12:298-309; PMID:10194461
   PubMed Web of Science ®Google Scholar
• Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci U S A 1992; 89:6901-5; PMID:1323121; http://dx.doi.org/10.1073/pnas.89.15.6901
   PubMed Web of Science ®Google Scholar
• Bian C, Liu S, Liu N, Zhang G, Xing L, Song Y, Duan Y, Gu H, Zhou Y, Zhang P, et al. Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice. Antiviral Res 2014; 104:110-7; PMID:24509239; http://dx.doi.org/10.1016/j.antiviral.2014.01.022
   PubMed Web of Science ®Google Scholar
• Gao X, Wang W, Li Y, Zhang S, Duan Y, Xing L, Zhao Z, Zhang P, Li Z, Li R, et al. Enhanced Influenza VLP vaccines comprising matrix-2 ectodomain and nucleoprotein epitopes protects mice from lethal challenge. Antiviral Res 2013; 98:4-11; PMID:23416215; http://dx.doi.org/10.1016/j.antiviral.2013.01.010
   PubMed Web of Science ®Google Scholar